Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE
Holding RARE?
Track your performance easily

Ultragenyx Pharmaceutical (RARE) Income Statement

744 Followers

Ultragenyx Pharmaceutical Income Statement

Last quarter (Q3 2024), Ultragenyx Pharmaceutical's total revenue was $139.49M, an increase of 42.27% from the same quarter last year. In Q3, Ultragenyx Pharmaceutical's net income was $-133.52M. See Ultragenyx Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 522.75M$ 434.25M$ 363.33M$ 351.41M$ 271.03M$ 103.71M
Cost of Revenue
-$ 45.21M--$ 6.13M$ 9.01M
Gross Profit
$ 522.75M$ 389.04M$ 363.33M$ 351.41M$ 264.90M$ 94.71M
Operating Expense
$ 974.55M$ 913.04M$ 955.61M$ 762.57M$ 595.02M$ 518.88M
Operating Income
$ -535.74M$ -569.21M$ -648.92M$ -411.16M$ -330.12M$ -424.17M
Net Non Operating Interest Income Expense
$ 35.51M$ 39.32M$ 11.07M$ 1.93M$ -26.25M$ 12.10M
Other Income Expense
$ -4.01M$ 60.00K$ 20.86M$ 43.75M$ 171.01M$ 12.63M
Pretax Income
$ -561.07M$ -608.46M$ -701.73M$ -452.98M$ -185.36M$ -399.44M
Tax Provision
$ -2.09M$ -1.82M$ 5.70M$ 1.04M$ 1.21M$ 3.28M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -558.99M$ -606.64M$ -607.77M$ -454.02M$ -186.57M$ -402.73M
Basic EPS
$ -6.47$ -8.25$ -10.12$ -6.70$ -3.07$ -7.12
Diluted EPS
$ -6.47$ -8.25$ -10.12$ -6.70$ -3.07$ -7.12
Basic Average Shares
$ 347.61M$ 73.54M$ 69.91M$ 67.80M$ 60.85M$ 56.58M
Diluted Average Shares
$ 347.61M$ 73.54M$ 69.91M$ 67.80M$ 60.85M$ 56.58M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 523.88M$ 1.00B$ 955.61M$ 762.57M$ 601.15M$ 527.89M
Net Income From Continuing And Discontinued Operation
$ -558.99M$ -606.64M$ -707.42M$ -454.02M$ -186.57M$ -402.73M
Normalized Income
$ -261.31M-$ -554.36M-$ -310.96M$ -412.52M
Interest Expense
----$ 33.29M$ 1.14M
EBIT
$ -400.80M$ -542.46M$ -701.69M$ 0.00$ -152.07M$ -398.31M
EBITDA
$ -374.34M$ -516.45M$ -680.77M$ 0.00$ -139.81M$ -389.77M
Currency in USD

Ultragenyx Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis